• 제목/요약/키워드: metabolic bone disease

검색결과 88건 처리시간 0.042초

Factors associated with Advanced Bone Age in Overweight and Obese Children

  • Oh, Min-Su;Kim, Sorina;Lee, Juyeon;Lee, Mu Sook;Kim, Yoon-Joo;Kang, Ki-Soo
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제23권1호
    • /
    • pp.89-97
    • /
    • 2020
  • Purpose: Obese children may often present with advanced bone age. We aimed to evaluate the correlation between factors associated with childhood obesity and advanced bone age. Methods: We enrolled 232 overweight or obese children. Anthropometric and laboratory data, and the degree of nonalcoholic fatty liver disease (NAFLD) were measured. We analyzed factors associated with advanced bone age by measuring the differences between bone and chronological ages. Results: The normal and advanced bone age groups were comprised of 183 (78.9%) and 49 (21.1%) children, respectively. The prevalence of advanced bone age significantly increased as the percentiles of height, weight, waist circumference, and body mass index (BMI) increased. BMI z-score was higher in the advanced bone age group than in the normal bone age group (2.43±0.52 vs. 2.10±0.46; p<0.001). The levels of insulin (27.80±26.13 μU/mL vs. 18.65±12.33 μU/mL; p=0.034) and homeostatic model assessment-insulin resistance (6.56±6.18 vs. 4.43±2.93; p=0.037) were significantly higher, while high density lipoprotein-cholesterol levels were lower (43.88±9.98 mg/dL vs. 48.95±10.50 mg/dL; p=0.005) in the advanced bone age group compared to those in the normal bone age group, respectively. The prevalence of advanced bone age was higher in obese children with metabolic syndrome than in those without (28.2% vs. 14.7%; p=0.016). The prevalence of advanced bone age was higher in obese children with a more severe degree of NAFLD. Conclusion: Advanced bone age is associated with a severe degree of obesity and its complications.

Mitochondrial calcium uniporter inhibition attenuates mouse bone marrow-derived mast cell degranulation induced by beta-1,3-glucan

  • Dang, Van Cuong;Kim, Hyoung Kyu;Marquez, Jubert;Kim, Nari;Ko, Kyung Soo;Rhee, Byoung Doo;Han, Jin
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제20권2호
    • /
    • pp.213-220
    • /
    • 2016
  • Mast cells are primary mediators of allergic inflammation. Beta-1,3-glucan (BG) protects against infection and shock by activating immune cells. Activation of the BG receptor induces an increase in intracellular $Ca^{2+}$, which may induce exocytosis. However, little is known about the precise mechanisms underlying BG activation of immune cells and the possible role of mitochondria in this process. The present study examined whether BG induced mast cell degranulation, and evaluated the role of calcium transients during mast cell activation. Our investigation focused on the role of the mitochondrial calcium uniporter (MCU) in BG-induced degranulation. Black mouse (C57) bone marrow-derived mast cells were stimulated with $0.5{\mu}g/ml$ BG, $100{\mu}g/ml$ peptidoglycan (PGN), or $10{\mu}M$ A23187 (calcium ionophore), and dynamic changes in cytosolic and mitochondrial calcium and membrane potential were monitored. BG-induced mast cell degranulation occurred in a time-dependent manner, and was significantly reduced under calcium-free conditions. Ruthenium red, a mitochondrial $Ca^{2+}$ uniporter blocker, significantly reduced mast cell degranulation induced by BG, PGN, and A23187. These results suggest that the mitochondrial $Ca^{2+}$ uniporter has an important regulatory role in BG-induced mast cell degranulation.

대사증후군 환자를 위한 생활습관정보 관리 시스템의 개발 (Development of Lifestyle Information Management System for Patients with Metabolic Syndrome)

  • 김지언;노시형;정창원;김태훈;전홍영;유태양;윤권하
    • 한국정보처리학회:학술대회논문집
    • /
    • 한국정보처리학회 2017년도 춘계학술발표대회
    • /
    • pp.609-610
    • /
    • 2017
  • 국내 외에서 잘못된 생활습관으로 대사증후군 환자가 급증하고 있다. 최근 대사증후군 환자들을 위한 웨어러블 디바이스를 이용하여 생활습관정보를 수집 분석하여 피드백하는 연구가 진행되고 있다. 생활습관 정보를 수집하는 대표적인 방법은 온라인/오프라인 설문지 또는 웨어러블 디바이스를 활용하여 수집하는 형태로 구분된다. 그러나 기존 설문지 방법은 연속적인 데이터를 얻기 어렵고, 웨어러블 디바이스를 이용하는 방법은 신뢰성 있는 데이터를 수집하기에는 한계가 있다. 따라서 본 논문에서는 대사증후군 환자를 대상으로 생활습관 정보 수집을 위한 병원의 설문지를 앱을 기반으로 개발하여 수집하고 스마트 폰과 밴드와 같은 웨어러블 디바이스를 이용하여 실시간 활동정보를 수집하여 환자 생활 습관에 따른 맞춤 별 예방정보를 제공하는 시스템을 제안하고자 한다.

대사증후군기반 의료 빅데이터 표준화 시스템의 설계 (Design of Medical Bigdata Standard System Based on Metabolic Syndrome)

  • 김지언;이기택;정창원;김규겸;김태훈;유종현;전홍영;장미연;이윤오;조은영;유태양;김대원;윤권하
    • 한국컴퓨터정보학회:학술대회논문집
    • /
    • 한국컴퓨터정보학회 2017년도 제55차 동계학술대회논문집 25권1호
    • /
    • pp.263-265
    • /
    • 2017
  • 본 논문에서는 대사증후군관련 의료 빅데이터 표준화 시스템의 환경과 소프트웨어 환경을 설계한 사항에 대해서 기술한다. 이를 위해 임상데이터를 기반으로 의료 빅데이터를 수집하고 국제 표준화인 공통 데이터 모델로 수집된 데이터를 ETL하여 통합 데이터베이스에 저장하였다. 본 연구를 통해 구축된 의료 빅데이터 표준화 시스템은 향후 의사결정 보조시스템 개발과 연계하여 효과적인 검색과 다양한 통계 분석을 지원할 계획이다. 또한 병원의 다양한 임상 연구를 지원하기 위한 주요 시스템으로 자리매김할 것으로 기대한다.

  • PDF

Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D

  • Park, Jung Eun;Pichiah, Tirupathi;Cha, Youn-Soo
    • Journal of Obesity & Metabolic Syndrome
    • /
    • 제27권4호
    • /
    • pp.223-232
    • /
    • 2018
  • Vitamin D, a free sunshine vitamin available for mankind from nature, is capable to avert many health-related critical circumstances. Vitamin D is no more regarded as a nutrient involved in bone metabolism alone. The presence of vitamin D receptor in a number of tissues implies that vitamin D has various physiological roles apart from calcium and phosphorus metabolism. Low serum vitamin D has been found to be associated with various types of metabolic illness such as obesity, diabetes mellitus, insulin resistance, cardiovascular diseases including hypertension. Various studies reported that vitamin D insufficiency or deficiency in linked with metabolic syndrome risk. This review focuses on various metabolic diseases and its relationship with serum vitamin D status.

$^{99m}Tc-MDP$를 이용한 Bone scan 시간(時間)에 관(關)한 고찰(考察) (A Study of Bone Scan Time by Use of $^{99m}Tc-MDP$)

  • 박성옥;이현배
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제17권1호
    • /
    • pp.77-86
    • /
    • 1994
  • The bone scan reflects the metabolic reaction of bone to a disease process, whether neoplastic, traumatic or inflammatory. In normal bone tissue, the labeled diphosphate complexes accumulate in the perivascular fluid next to the marrow cavity at the interface between uncalcified and calcified bone matrix. HMDP has the most rapid plasma clearance among the commonly used diphosphonate followed by MDP and then HEDP. I have studied about bone scan time by use of $^{99m}Tc-MDP$, and got 336 images from 112 patients. The result obtained as follow; 1. Accumulation rate of $^{99m}Tc-MDP$ is higher than other age groups in below 30-year old group. 2. Accumulation rate, in 10year old group, is 75.85% on 120min. but other groups are most high on 180 min. 3. The density differants between bone and soft tissue increased with time. 4. Image contrast is good in younger group than old.

  • PDF

내분비계 이상을 동반하는 선천성대사질환 (Endocrine Manifestations Related with Inborn Errors of Metabolism)

  • 이정호
    • 대한유전성대사질환학회지
    • /
    • 제22권2호
    • /
    • pp.46-52
    • /
    • 2022
  • Inborn errors of metabolism (IEM) are very rare and genetically transmitted diseases and have man y different symptoms related with multisystemic involvement. More rarely, endocrinopathies can be an early and first symptom of IEM, but presents with signs of later complications in adolescent or adulthood. The mechanisms of endocrine dysfunction in IEM are poorly understood. Hypogonadotropic hypogonadism is common in hemochromatosis, adrenoleukodystrophy, galactosemia, and glycogen storage disease. Many girls with classic galactosemia are at high risk for premature ovarian insufficiency (POI), despite an early diagnosis and good control. Mitochondrial diseases are multisystem disorders and are characterized by hypo- and hypergonadotrophic hypogonadism, thyroid dysfunction and insulin dysregulation. Glycogen storage disorders (GSDs), especially type Ia, Ib, III, V are assocciated with frequent hypoglycemic events. IEM is a growing field and is not yet well recognized despite its consequences for growth, bone metabolism and fertility. For this reason, clinicians should be aware of these diagnoses and potential endocrine dysfunction.

High Glucose Inhibitory Effects on Bone Formation in UMR106 Cells

  • Kwon, Eun-Hee;Jung, In-Ok;Kim, Sung-Jin
    • Biomolecules & Therapeutics
    • /
    • 제11권2호
    • /
    • pp.81-84
    • /
    • 2003
  • Recently, diabetes has been found to be associated with osteoporosis. Specially in IDDM. In both type I and type II diabetes, glucose levels are elevated. Thus, a linkage between high glucose and osteoporosis can not be ruled out. In this study, an attempt has been made to observe the effect of high glucose on bone formation; osteoblast like UMR 106 cells were treated with high glucose (22 mM, 33 mM) for 1, 3 or 7 days. The high concentration of glucose inhibited markers. of bone formation activity such as alkaline phosphatase and collagen synthesis. In addition, reduction in the level of total cellular protein in response to high glucose was also observed. This study showed high glucose concentration could alter the bone metabolism leading to a defective bone formation and thus paving the linkage of such situation to diabetic complications.

Caucher 환자의 효소 대치요법에 따른 Chititriosidase 활성도 변화 (Change of Chitotriosidase activity in Gaucher Patients by Enzyme Replacement Therapy)

  • 유한욱;임대성;양송현
    • 대한유전성대사질환학회지
    • /
    • 제6권1호
    • /
    • pp.58-62
    • /
    • 2006
  • Gaucher disease is an inherited disorder due to a deficiency in the activity of glucocerebrosidase (EC. 3.2.1.45) by genetic mutation which resulted from missense, nonsense, frameshift, deletion in long arm 21 of chromosome 1 (1q21). Gaucher disease is classified into the main three types as type 1 (nonneuronopathic), type 2 (acute neuronopathic) and type 3 (subacute neuronopathic) according to the progressive phase of manifestations and nervous system involvement. Gaucher disease patients had been treated by using the method as splenectomy and bone marrow transplantation. But enzyme replacement therapy as a more effective treatment has been available since the early 1990's. In order to treat Gaucher disease efficiently by using ERT, it is necessary to chase the progress of the therapy. In this study, therefore, we tried to chase the progress of the ERT by using the measurement of chitotriosidase activity in Gaucher disease patients.

  • PDF

The role of myokine Irisin on bone metabolism

  • Lee, Jin-Wook;Kim, Chan-Yang
    • 한국컴퓨터정보학회논문지
    • /
    • 제24권9호
    • /
    • pp.97-102
    • /
    • 2019
  • Several studies have recently demonstrated that skeletal muscle is an endocrine organ releasing and expressing myokines acting in an endocrine or paracrine manner. Irisin is a hormene-like myokine induced after physical exercise by muscle fibers. It was primarily recognized as a molecule able to advance the "browning response" in white adipose tissue, however, it has been recetly identified that irisin also has a fundamental role in the control of bone mass. We study evidence for its possible skeletal effects, including the fundamental role that irisin is involved in the control of bone mass, with beneficial effects on geometry and cortical mineral density. As loss of muscle mass and bone density occurs with immobility, metabolic disease and aging, future studies researching the efficacy of irisin in reversing muscle wasting and restoring bone would be important to proving irisin as a molecule that combines helpful effects for treating muscular atrophy and osteoporosis in elderly people.